{
  "metadata": {
    "graph_path": "./logic_graph.png",
    "num_solutions": 4,
    "family_stats": {
      "1": {
        "core": 1,
        "branch": 0
      },
      "2": {
        "core": 1,
        "branch": 1
      },
      "3": {
        "core": 1,
        "branch": 0
      }
    }
  },
  "knowledge_base": {
    "rules": [
      {
        "id": "Rule1",
        "formal": "(A10 → A11)",
        "prover9_expression": "(identified_potential(drug_x) -> confirmed_safety(drug_x))",
        "natural": "If the potential of Drug X was identified, then the safety of Drug X was confirmed."
      },
      {
        "id": "Rule2",
        "formal": "(A10 → A12)",
        "prover9_expression": "(identified_potential(drug_x) -> completed_phase_one(drug_x))",
        "natural": "Provided that the potential of Drug X was identified, phase one of Drug X was completed."
      },
      {
        "id": "Rule3",
        "formal": "(A12 → A13)",
        "prover9_expression": "(completed_phase_one(drug_x) -> entered_phase_two(drug_x))",
        "natural": "Under the condition that phase one of Drug X was completed, Drug X entered phase two."
      },
      {
        "id": "Rule4",
        "formal": "(A14 → A15)",
        "prover9_expression": "(received_regulatory_approval(drug_x) -> launched_commercial(drug_x))",
        "natural": "Whenever Drug X received regulatory approval, Drug X was launched commercially."
      },
      {
        "id": "Rule5",
        "formal": "(A14 ∨ (A13 → ¬A11))",
        "prover9_expression": "(received_regulatory_approval(drug_x) | (entered_phase_two(drug_x) -> -confirmed_safety(drug_x)))",
        "natural": "Either Drug X received regulatory approval or, if Drug X entered phase two, then the safety of Drug X was not confirmed."
      },
      {
        "id": "Rule6",
        "formal": "(A16 ∨ ¬A15)",
        "prover9_expression": "(partnered_pharma(drug_x) | -launched_commercial(drug_x))",
        "natural": "Drug X partnered with a pharma company or Drug X was not launched commercially."
      },
      {
        "id": "Rule7",
        "formal": "(A17 → (¬G → A5))",
        "prover9_expression": "(submitted_application(research_team) -> (-government_agency(fda) -> approved_for_human_trial(drug_x)))",
        "natural": "If the research team submitted an application, then, should the FDA not be a government agency, Drug X was approved for human trial."
      },
      {
        "id": "Rule8",
        "formal": "(A18 → (¬G → A5))",
        "prover9_expression": "(awaited_review(research_team) -> (-government_agency(fda) -> approved_for_human_trial(drug_x)))",
        "natural": "Provided that the research team awaited review, then, in the event that the FDA is not a government agency, Drug X was approved for human trial."
      },
      {
        "id": "Rule9",
        "formal": "(A19 → A17)",
        "prover9_expression": "(compiled_data(research_team) -> submitted_application(research_team))",
        "natural": "Under the condition that the research team compiled data, the research team submitted an application."
      },
      {
        "id": "Rule10",
        "formal": "(A19 ∨ A20)",
        "prover9_expression": "(compiled_data(research_team) | prepared_documents(research_team))",
        "natural": "Either the research team compiled data or the research team prepared documents."
      },
      {
        "id": "Rule11",
        "formal": "(A2 → ¬A1)",
        "prover9_expression": "(published_results(study_a, journal_b) -> -tested_successfully(drug_x))",
        "natural": "If the results of Study A were published in Journal B, then Drug X was not tested successfully."
      },
      {
        "id": "Rule12",
        "formal": "(A20 → A21)",
        "prover9_expression": "(prepared_documents(research_team) -> finalized_report(research_team))",
        "natural": "Provided that the research team prepared documents, the research team finalized a report."
      },
      {
        "id": "Rule13",
        "formal": "(A21 → A22)",
        "prover9_expression": "(finalized_report(research_team) -> sent_package(research_team))",
        "natural": "Under the condition that the research team finalized a report, the research team sent a package."
      },
      {
        "id": "Rule14",
        "formal": "(A22 → A18)",
        "prover9_expression": "(sent_package(research_team) -> awaited_review(research_team))",
        "natural": "Whenever the research team sent a package, the research team awaited review."
      },
      {
        "id": "Rule15",
        "formal": "(A4 → (A3 ∨ A2))",
        "prover9_expression": "(received_funding(research_team) -> (presented_findings(study_a, conference_c) | published_results(study_a, journal_b)))",
        "natural": "If the research team received funding, then either the findings of Study A were presented at Conference C or the results of Study A were published in Journal B."
      },
      {
        "id": "Rule16",
        "formal": "(A7 → A6)",
        "prover9_expression": "(analyzed_toxicity(drug_x, material_e) -> conducted_animal_testing(drug_x, species_d))",
        "natural": "Provided that the toxicity of Drug X was analyzed using Material E, animal testing of Drug X was conducted on Species D."
      },
      {
        "id": "Rule17",
        "formal": "(A9 → ¬A8)",
        "prover9_expression": "(continued_research(drug_x) -> -halted_development(drug_x))",
        "natural": "If research on Drug X was continued, then the development of Drug X was not halted."
      },
      {
        "id": "Rule18",
        "formal": "(¬(¬(¬G → A5) → A7) → A8)",
        "prover9_expression": "(-(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> analyzed_toxicity(drug_x, material_e)) -> halted_development(drug_x))",
        "natural": "If it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, then the development of Drug X was halted."
      },
      {
        "id": "Rule19",
        "formal": "(¬(¬(¬G → A5) → A7) → A9)",
        "prover9_expression": "(-(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> analyzed_toxicity(drug_x, material_e)) -> continued_research(drug_x))",
        "natural": "Under the condition that it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, research on Drug X was continued."
      },
      {
        "id": "Rule20",
        "formal": "(¬(¬G → A5) → ¬A6)",
        "prover9_expression": "(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> -conducted_animal_testing(drug_x, species_d))",
        "natural": "Under the condition that it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, it is not the case that animal testing of Drug X was conducted on Species D."
      },
      {
        "id": "Rule21",
        "formal": "(¬G → A1)",
        "prover9_expression": "(-government_agency(fda) -> tested_successfully(drug_x))",
        "natural": "Whenever the FDA is not a government agency, Drug X was tested successfully."
      },
      {
        "id": "Rule22",
        "formal": "(¬G → A10)",
        "prover9_expression": "(-government_agency(fda) -> identified_potential(drug_x))",
        "natural": "Provided that the FDA is not a government agency, the potential of Drug X was identified."
      }
    ],
    "facts": [
      {
        "id": "Fact1",
        "formal": "A4",
        "prover9_expression": "received_funding(research_team)",
        "natural": "The research team received funding."
      },
      {
        "id": "Fact2",
        "formal": "¬A16",
        "prover9_expression": "-partnered_pharma(drug_x)",
        "natural": "A partnership with a pharmaceutical company for Drug X does not hold."
      },
      {
        "id": "Fact3",
        "formal": "¬A3",
        "prover9_expression": "-presented_findings(study_a, conference_c)",
        "natural": "The findings of Study A were not presented at Conference C."
      },
      {
        "id": "Fact4",
        "formal": "¬A5",
        "prover9_expression": "-approved_for_human_trial(drug_x)",
        "natural": "Drug X was not approved for human trial."
      }
    ]
  },
  "target": {
    "formal": "G",
    "prover9": "G",
    "prover9_expression": "government_agency(fda)",
    "natural": "The FDA is a government agency."
  },
  "solutions": [
    {
      "id": 1,
      "family_id": 1,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "MP",
          "premises_used": [
            "(A4 -> (A3 | A2))",
            "A4"
          ],
          "conclusion": "(A3 | A2)",
          "natural": "Either the findings of Study A were presented at Conference C or the results of Study A were published in Journal B."
        },
        {
          "step_number": 2,
          "rule_applied": "DS",
          "premises_used": [
            "(A3 | A2)",
            "-A3"
          ],
          "conclusion": "A2",
          "natural": "The results of Study A were published in Journal B."
        },
        {
          "step_number": 3,
          "rule_applied": "MP",
          "premises_used": [
            "(A2 -> -A1)",
            "A2"
          ],
          "conclusion": "-A1",
          "natural": "It is not the case that Drug X was tested successfully."
        },
        {
          "step_number": 4,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A1)",
            "-A1"
          ],
          "conclusion": "G",
          "natural": "The FDA is a government agency."
        }
      ]
    },
    {
      "id": 2,
      "family_id": 2,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-(-G -> A5) -> A7) -> A9)",
            "(A9 -> -A8)"
          ],
          "conclusion": "(-(-(-G -> A5) -> A7) -> -A8)",
          "natural": "Whenever it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, it is not the case that the development of Drug X was halted."
        },
        {
          "step_number": 2,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-(-G -> A5) -> A7) -> A8)",
            "(-(-(-G -> A5) -> A7) -> -A8)"
          ],
          "conclusion": "(-(-G -> A5) -> A7)",
          "natural": "If it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E."
        },
        {
          "step_number": 3,
          "rule_applied": "HS",
          "premises_used": [
            "(-(-G -> A5) -> A7)",
            "(A7 -> A6)"
          ],
          "conclusion": "(-(-G -> A5) -> A6)",
          "natural": "Provided that it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, animal testing of Drug X was conducted on Species D."
        },
        {
          "step_number": 4,
          "rule_applied": "RAA",
          "premises_used": [
            "(-(-G -> A5) -> A6)",
            "(-(-G -> A5) -> -A6)"
          ],
          "conclusion": "(-G -> A5)",
          "natural": "If the FDA is not a government agency, then Drug X was approved for human trial."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A5)",
            "-A5"
          ],
          "conclusion": "G",
          "natural": "The FDA is a government agency."
        }
      ]
    },
    {
      "id": 3,
      "family_id": 3,
      "path_type": "core",
      "branch_from": null,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "DS",
          "premises_used": [
            "(A16 | -A15)",
            "-A16"
          ],
          "conclusion": "-A15",
          "natural": "Drug X was not launched commercially."
        },
        {
          "step_number": 2,
          "rule_applied": "MT",
          "premises_used": [
            "(A14 -> A15)",
            "-A15"
          ],
          "conclusion": "-A14",
          "natural": "Drug X did not receive regulatory approval."
        },
        {
          "step_number": 3,
          "rule_applied": "DS",
          "premises_used": [
            "(A14 | (A13 -> -A11))",
            "-A14"
          ],
          "conclusion": "(A13 -> -A11)",
          "natural": "Provided that Drug X entered phase two, the safety of Drug X does not hold."
        },
        {
          "step_number": 4,
          "rule_applied": "HS",
          "premises_used": [
            "(A12 -> A13)",
            "(A13 -> -A11)"
          ],
          "conclusion": "(A12 -> -A11)",
          "natural": "If phase one of Drug X was completed, then the safety of Drug X was not confirmed."
        },
        {
          "step_number": 5,
          "rule_applied": "HS",
          "premises_used": [
            "(A10 -> A12)",
            "(A12 -> -A11)"
          ],
          "conclusion": "(A10 -> -A11)",
          "natural": "Whenever the potential of Drug X was identified, it is not the case that the safety of Drug X was confirmed."
        },
        {
          "step_number": 6,
          "rule_applied": "RAA",
          "premises_used": [
            "(A10 -> A11)",
            "(A10 -> -A11)"
          ],
          "conclusion": "-A10",
          "natural": "Drug X's potential was not identified."
        },
        {
          "step_number": 7,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A10)",
            "-A10"
          ],
          "conclusion": "G",
          "natural": "The FDA is a government agency."
        }
      ]
    },
    {
      "id": 4,
      "family_id": 2,
      "path_type": "branch",
      "branch_from": 3,
      "steps": [
        {
          "step_number": 1,
          "rule_applied": "HS",
          "premises_used": [
            "(A21 -> A22)",
            "(A22 -> A18)"
          ],
          "conclusion": "(A21 -> A18)",
          "natural": "If the research team finalized a report, then the research team awaited review."
        },
        {
          "step_number": 2,
          "rule_applied": "HS",
          "premises_used": [
            "(A20 -> A21)",
            "(A21 -> A18)"
          ],
          "conclusion": "(A20 -> A18)",
          "natural": "Whenever the research team prepared documents, the research team awaited review."
        },
        {
          "step_number": 3,
          "rule_applied": "CD",
          "premises_used": [
            "(A19 -> A17)",
            "(A20 -> A18)",
            "(A19 | A20)"
          ],
          "conclusion": "(A17 | A18)",
          "natural": "The research team submitted an application or the research team awaited review."
        },
        {
          "step_number": 4,
          "rule_applied": "DE",
          "premises_used": [
            "(A17 | A18)",
            "(A17 -> (-G -> A5))",
            "(A18 -> (-G -> A5))"
          ],
          "conclusion": "(-G -> A5)",
          "natural": "If the FDA is not a government agency, then Drug X was approved for human trial."
        },
        {
          "step_number": 5,
          "rule_applied": "MT",
          "premises_used": [
            "(-G -> A5)",
            "-A5"
          ],
          "conclusion": "G",
          "natural": "The FDA is a government agency."
        }
      ]
    }
  ],
  "translations": {
    "domain_theme": "Pharmaceutical Research",
    "atomic_facts": {
      "A1": "tested_successfully(drug_x)",
      "A2": "published_results(study_a, journal_b)",
      "A3": "presented_findings(study_a, conference_c)",
      "A4": "received_funding(research_team)",
      "A5": "approved_for_human_trial(drug_x)",
      "A6": "conducted_animal_testing(drug_x, species_d)",
      "A7": "analyzed_toxicity(drug_x, material_e)",
      "A8": "halted_development(drug_x)",
      "A9": "continued_research(drug_x)",
      "A10": "identified_potential(drug_x)",
      "A11": "confirmed_safety(drug_x)",
      "A12": "completed_phase_one(drug_x)",
      "A13": "entered_phase_two(drug_x)",
      "A14": "received_regulatory_approval(drug_x)",
      "A15": "launched_commercial(drug_x)",
      "A16": "partnered_pharma(drug_x)",
      "A17": "submitted_application(research_team)",
      "A18": "awaited_review(research_team)",
      "A19": "compiled_data(research_team)",
      "A20": "prepared_documents(research_team)",
      "A21": "finalized_report(research_team)",
      "A22": "sent_package(research_team)",
      "G": "government_agency(fda)"
    },
    "natural_facts": {
      "A1": "Drug X was tested successfully.",
      "A2": "The results of Study A were published in Journal B.",
      "A3": "The findings of Study A were presented at Conference C.",
      "A4": "The research team received funding.",
      "A5": "Drug X was approved for human trial.",
      "A6": "Animal testing of Drug X was conducted on Species D.",
      "A7": "The toxicity of Drug X was analyzed using Material E.",
      "A8": "The development of Drug X was halted.",
      "A9": "Research on Drug X was continued.",
      "A10": "The potential of Drug X was identified.",
      "A11": "The safety of Drug X was confirmed.",
      "A12": "Phase one of Drug X was completed.",
      "A13": "Drug X entered phase two.",
      "A14": "Drug X received regulatory approval.",
      "A15": "Drug X was launched commercially.",
      "A16": "A partnership with a pharmaceutical company was formed for Drug X.",
      "A17": "The research team submitted an application.",
      "A18": "The research team awaited review.",
      "A19": "The research team compiled data.",
      "A20": "The research team prepared documents.",
      "A21": "The research team finalized a report.",
      "A22": "The research team sent a package.",
      "G": "The FDA is a government agency."
    },
    "prover9_expressions": [
      "(identified_potential(drug_x) -> confirmed_safety(drug_x))",
      "(identified_potential(drug_x) -> completed_phase_one(drug_x))",
      "(identified_potential(drug_x) -> -confirmed_safety(drug_x))",
      "(completed_phase_one(drug_x) -> entered_phase_two(drug_x))",
      "(completed_phase_one(drug_x) -> -confirmed_safety(drug_x))",
      "(entered_phase_two(drug_x) -> -confirmed_safety(drug_x))",
      "(received_regulatory_approval(drug_x) -> launched_commercial(drug_x))",
      "(received_regulatory_approval(drug_x) | (entered_phase_two(drug_x) -> -confirmed_safety(drug_x)))",
      "(partnered_pharma(drug_x) | -launched_commercial(drug_x))",
      "(submitted_application(research_team) -> (-government_agency(fda) -> approved_for_human_trial(drug_x)))",
      "(submitted_application(research_team) | awaited_review(research_team))",
      "(awaited_review(research_team) -> (-government_agency(fda) -> approved_for_human_trial(drug_x)))",
      "(compiled_data(research_team) -> submitted_application(research_team))",
      "(compiled_data(research_team) | prepared_documents(research_team))",
      "(published_results(study_a, journal_b) -> -tested_successfully(drug_x))",
      "(prepared_documents(research_team) -> awaited_review(research_team))",
      "(prepared_documents(research_team) -> finalized_report(research_team))",
      "(finalized_report(research_team) -> awaited_review(research_team))",
      "(finalized_report(research_team) -> sent_package(research_team))",
      "(sent_package(research_team) -> awaited_review(research_team))",
      "(presented_findings(study_a, conference_c) | published_results(study_a, journal_b))",
      "(received_funding(research_team) -> (presented_findings(study_a, conference_c) | published_results(study_a, journal_b)))",
      "(analyzed_toxicity(drug_x, material_e) -> conducted_animal_testing(drug_x, species_d))",
      "(continued_research(drug_x) -> -halted_development(drug_x))",
      "(-(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> analyzed_toxicity(drug_x, material_e)) -> halted_development(drug_x))",
      "(-(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> analyzed_toxicity(drug_x, material_e)) -> continued_research(drug_x))",
      "(-(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> analyzed_toxicity(drug_x, material_e)) -> -halted_development(drug_x))",
      "(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> conducted_animal_testing(drug_x, species_d))",
      "(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> analyzed_toxicity(drug_x, material_e))",
      "(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> -conducted_animal_testing(drug_x, species_d))",
      "(-government_agency(fda) -> tested_successfully(drug_x))",
      "(-government_agency(fda) -> identified_potential(drug_x))",
      "(-government_agency(fda) -> approved_for_human_trial(drug_x))",
      "published_results(study_a, journal_b)",
      "received_funding(research_team)",
      "government_agency(fda)",
      "-tested_successfully(drug_x)",
      "-identified_potential(drug_x)",
      "-received_regulatory_approval(drug_x)",
      "-launched_commercial(drug_x)",
      "-partnered_pharma(drug_x)",
      "-presented_findings(study_a, conference_c)",
      "-approved_for_human_trial(drug_x)"
    ],
    "natural_expressions": [
      "If the potential of Drug X was identified, then the safety of Drug X was confirmed.",
      "Provided that the potential of Drug X was identified, phase one of Drug X was completed.",
      "Whenever the potential of Drug X was identified, it is not the case that the safety of Drug X was confirmed.",
      "Under the condition that phase one of Drug X was completed, Drug X entered phase two.",
      "If phase one of Drug X was completed, then the safety of Drug X was not confirmed.",
      "Provided that Drug X entered phase two, the safety of Drug X does not hold.",
      "Whenever Drug X received regulatory approval, Drug X was launched commercially.",
      "Either Drug X received regulatory approval or, if Drug X entered phase two, then the safety of Drug X was not confirmed.",
      "Drug X partnered with a pharma company or Drug X was not launched commercially.",
      "If the research team submitted an application, then, should the FDA not be a government agency, Drug X was approved for human trial.",
      "The research team submitted an application or the research team awaited review.",
      "Provided that the research team awaited review, then, in the event that the FDA is not a government agency, Drug X was approved for human trial.",
      "Under the condition that the research team compiled data, the research team submitted an application.",
      "Either the research team compiled data or the research team prepared documents.",
      "If the results of Study A were published in Journal B, then Drug X was not tested successfully.",
      "Whenever the research team prepared documents, the research team awaited review.",
      "Provided that the research team prepared documents, the research team finalized a report.",
      "If the research team finalized a report, then the research team awaited review.",
      "Under the condition that the research team finalized a report, the research team sent a package.",
      "Whenever the research team sent a package, the research team awaited review.",
      "Either the findings of Study A were presented at Conference C or the results of Study A were published in Journal B.",
      "If the research team received funding, then either the findings of Study A were presented at Conference C or the results of Study A were published in Journal B.",
      "Provided that the toxicity of Drug X was analyzed using Material E, animal testing of Drug X was conducted on Species D.",
      "If research on Drug X was continued, then the development of Drug X was not halted.",
      "If it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, then the development of Drug X was halted.",
      "Under the condition that it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, research on Drug X was continued.",
      "Whenever it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, it is not the case that the development of Drug X was halted.",
      "Provided that it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, animal testing of Drug X was conducted on Species D.",
      "If it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E.",
      "Under the condition that it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, it is not the case that animal testing of Drug X was conducted on Species D.",
      "Whenever the FDA is not a government agency, Drug X was tested successfully.",
      "Provided that the FDA is not a government agency, the potential of Drug X was identified.",
      "If the FDA is not a government agency, then Drug X was approved for human trial.",
      "The results of Study A were published in Journal B.",
      "The research team received funding.",
      "The FDA is a government agency.",
      "It is not the case that Drug X was tested successfully.",
      "Drug X's potential was not identified.",
      "Drug X did not receive regulatory approval.",
      "Drug X was not launched commercially.",
      "A partnership with a pharmaceutical company for Drug X does not hold.",
      "The findings of Study A were not presented at Conference C.",
      "Drug X was not approved for human trial."
    ],
    "node_mappings": {
      "(A10 → A11)": {
        "formal": "(A10 → A11)",
        "prover9": "(A10 -> A11)",
        "prover9_expression": "(identified_potential(drug_x) -> confirmed_safety(drug_x))",
        "natural": "If the potential of Drug X was identified, then the safety of Drug X was confirmed."
      },
      "(A10 → A12)": {
        "formal": "(A10 → A12)",
        "prover9": "(A10 -> A12)",
        "prover9_expression": "(identified_potential(drug_x) -> completed_phase_one(drug_x))",
        "natural": "Provided that the potential of Drug X was identified, phase one of Drug X was completed."
      },
      "(A10 → ¬A11)": {
        "formal": "(A10 → ¬A11)",
        "prover9": "(A10 -> -A11)",
        "prover9_expression": "(identified_potential(drug_x) -> -confirmed_safety(drug_x))",
        "natural": "Whenever the potential of Drug X was identified, it is not the case that the safety of Drug X was confirmed."
      },
      "(A12 → A13)": {
        "formal": "(A12 → A13)",
        "prover9": "(A12 -> A13)",
        "prover9_expression": "(completed_phase_one(drug_x) -> entered_phase_two(drug_x))",
        "natural": "Under the condition that phase one of Drug X was completed, Drug X entered phase two."
      },
      "(A12 → ¬A11)": {
        "formal": "(A12 → ¬A11)",
        "prover9": "(A12 -> -A11)",
        "prover9_expression": "(completed_phase_one(drug_x) -> -confirmed_safety(drug_x))",
        "natural": "If phase one of Drug X was completed, then the safety of Drug X was not confirmed."
      },
      "(A13 → ¬A11)": {
        "formal": "(A13 → ¬A11)",
        "prover9": "(A13 -> -A11)",
        "prover9_expression": "(entered_phase_two(drug_x) -> -confirmed_safety(drug_x))",
        "natural": "Provided that Drug X entered phase two, the safety of Drug X does not hold."
      },
      "(A14 → A15)": {
        "formal": "(A14 → A15)",
        "prover9": "(A14 -> A15)",
        "prover9_expression": "(received_regulatory_approval(drug_x) -> launched_commercial(drug_x))",
        "natural": "Whenever Drug X received regulatory approval, Drug X was launched commercially."
      },
      "(A14 ∨ (A13 → ¬A11))": {
        "formal": "(A14 ∨ (A13 → ¬A11))",
        "prover9": "(A14 | (A13 -> -A11))",
        "prover9_expression": "(received_regulatory_approval(drug_x) | (entered_phase_two(drug_x) -> -confirmed_safety(drug_x)))",
        "natural": "Either Drug X received regulatory approval or, if Drug X entered phase two, then the safety of Drug X was not confirmed."
      },
      "(A16 ∨ ¬A15)": {
        "formal": "(A16 ∨ ¬A15)",
        "prover9": "(A16 | -A15)",
        "prover9_expression": "(partnered_pharma(drug_x) | -launched_commercial(drug_x))",
        "natural": "Drug X partnered with a pharma company or Drug X was not launched commercially."
      },
      "(A17 → (¬G → A5))": {
        "formal": "(A17 → (¬G → A5))",
        "prover9": "(A17 -> (-G -> A5))",
        "prover9_expression": "(submitted_application(research_team) -> (-government_agency(fda) -> approved_for_human_trial(drug_x)))",
        "natural": "If the research team submitted an application, then, should the FDA not be a government agency, Drug X was approved for human trial."
      },
      "(A17 ∨ A18)": {
        "formal": "(A17 ∨ A18)",
        "prover9": "(A17 | A18)",
        "prover9_expression": "(submitted_application(research_team) | awaited_review(research_team))",
        "natural": "The research team submitted an application or the research team awaited review."
      },
      "(A18 → (¬G → A5))": {
        "formal": "(A18 → (¬G → A5))",
        "prover9": "(A18 -> (-G -> A5))",
        "prover9_expression": "(awaited_review(research_team) -> (-government_agency(fda) -> approved_for_human_trial(drug_x)))",
        "natural": "Provided that the research team awaited review, then, in the event that the FDA is not a government agency, Drug X was approved for human trial."
      },
      "(A19 → A17)": {
        "formal": "(A19 → A17)",
        "prover9": "(A19 -> A17)",
        "prover9_expression": "(compiled_data(research_team) -> submitted_application(research_team))",
        "natural": "Under the condition that the research team compiled data, the research team submitted an application."
      },
      "(A19 ∨ A20)": {
        "formal": "(A19 ∨ A20)",
        "prover9": "(A19 | A20)",
        "prover9_expression": "(compiled_data(research_team) | prepared_documents(research_team))",
        "natural": "Either the research team compiled data or the research team prepared documents."
      },
      "(A2 → ¬A1)": {
        "formal": "(A2 → ¬A1)",
        "prover9": "(A2 -> -A1)",
        "prover9_expression": "(published_results(study_a, journal_b) -> -tested_successfully(drug_x))",
        "natural": "If the results of Study A were published in Journal B, then Drug X was not tested successfully."
      },
      "(A20 → A18)": {
        "formal": "(A20 → A18)",
        "prover9": "(A20 -> A18)",
        "prover9_expression": "(prepared_documents(research_team) -> awaited_review(research_team))",
        "natural": "Whenever the research team prepared documents, the research team awaited review."
      },
      "(A20 → A21)": {
        "formal": "(A20 → A21)",
        "prover9": "(A20 -> A21)",
        "prover9_expression": "(prepared_documents(research_team) -> finalized_report(research_team))",
        "natural": "Provided that the research team prepared documents, the research team finalized a report."
      },
      "(A21 → A18)": {
        "formal": "(A21 → A18)",
        "prover9": "(A21 -> A18)",
        "prover9_expression": "(finalized_report(research_team) -> awaited_review(research_team))",
        "natural": "If the research team finalized a report, then the research team awaited review."
      },
      "(A21 → A22)": {
        "formal": "(A21 → A22)",
        "prover9": "(A21 -> A22)",
        "prover9_expression": "(finalized_report(research_team) -> sent_package(research_team))",
        "natural": "Under the condition that the research team finalized a report, the research team sent a package."
      },
      "(A22 → A18)": {
        "formal": "(A22 → A18)",
        "prover9": "(A22 -> A18)",
        "prover9_expression": "(sent_package(research_team) -> awaited_review(research_team))",
        "natural": "Whenever the research team sent a package, the research team awaited review."
      },
      "(A3 ∨ A2)": {
        "formal": "(A3 ∨ A2)",
        "prover9": "(A3 | A2)",
        "prover9_expression": "(presented_findings(study_a, conference_c) | published_results(study_a, journal_b))",
        "natural": "Either the findings of Study A were presented at Conference C or the results of Study A were published in Journal B."
      },
      "(A4 → (A3 ∨ A2))": {
        "formal": "(A4 → (A3 ∨ A2))",
        "prover9": "(A4 -> (A3 | A2))",
        "prover9_expression": "(received_funding(research_team) -> (presented_findings(study_a, conference_c) | published_results(study_a, journal_b)))",
        "natural": "If the research team received funding, then either the findings of Study A were presented at Conference C or the results of Study A were published in Journal B."
      },
      "(A7 → A6)": {
        "formal": "(A7 → A6)",
        "prover9": "(A7 -> A6)",
        "prover9_expression": "(analyzed_toxicity(drug_x, material_e) -> conducted_animal_testing(drug_x, species_d))",
        "natural": "Provided that the toxicity of Drug X was analyzed using Material E, animal testing of Drug X was conducted on Species D."
      },
      "(A9 → ¬A8)": {
        "formal": "(A9 → ¬A8)",
        "prover9": "(A9 -> -A8)",
        "prover9_expression": "(continued_research(drug_x) -> -halted_development(drug_x))",
        "natural": "If research on Drug X was continued, then the development of Drug X was not halted."
      },
      "(¬(¬(¬G → A5) → A7) → A8)": {
        "formal": "(¬(¬(¬G → A5) → A7) → A8)",
        "prover9": "(-(-(-G -> A5) -> A7) -> A8)",
        "prover9_expression": "(-(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> analyzed_toxicity(drug_x, material_e)) -> halted_development(drug_x))",
        "natural": "If it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, then the development of Drug X was halted."
      },
      "(¬(¬(¬G → A5) → A7) → A9)": {
        "formal": "(¬(¬(¬G → A5) → A7) → A9)",
        "prover9": "(-(-(-G -> A5) -> A7) -> A9)",
        "prover9_expression": "(-(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> analyzed_toxicity(drug_x, material_e)) -> continued_research(drug_x))",
        "natural": "Under the condition that it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, research on Drug X was continued."
      },
      "(¬(¬(¬G → A5) → A7) → ¬A8)": {
        "formal": "(¬(¬(¬G → A5) → A7) → ¬A8)",
        "prover9": "(-(-(-G -> A5) -> A7) -> -A8)",
        "prover9_expression": "(-(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> analyzed_toxicity(drug_x, material_e)) -> -halted_development(drug_x))",
        "natural": "Whenever it is not the case that, if it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E, it is not the case that the development of Drug X was halted."
      },
      "(¬(¬G → A5) → A6)": {
        "formal": "(¬(¬G → A5) → A6)",
        "prover9": "(-(-G -> A5) -> A6)",
        "prover9_expression": "(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> conducted_animal_testing(drug_x, species_d))",
        "natural": "Provided that it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, animal testing of Drug X was conducted on Species D."
      },
      "(¬(¬G → A5) → A7)": {
        "formal": "(¬(¬G → A5) → A7)",
        "prover9": "(-(-G -> A5) -> A7)",
        "prover9_expression": "(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> analyzed_toxicity(drug_x, material_e))",
        "natural": "If it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, then the toxicity of Drug X was analyzed using Material E."
      },
      "(¬(¬G → A5) → ¬A6)": {
        "formal": "(¬(¬G → A5) → ¬A6)",
        "prover9": "(-(-G -> A5) -> -A6)",
        "prover9_expression": "(-(-government_agency(fda) -> approved_for_human_trial(drug_x)) -> -conducted_animal_testing(drug_x, species_d))",
        "natural": "Under the condition that it is not the case that, if the FDA is not a government agency then Drug X was approved for human trial, it is not the case that animal testing of Drug X was conducted on Species D."
      },
      "(¬G → A1)": {
        "formal": "(¬G → A1)",
        "prover9": "(-G -> A1)",
        "prover9_expression": "(-government_agency(fda) -> tested_successfully(drug_x))",
        "natural": "Whenever the FDA is not a government agency, Drug X was tested successfully."
      },
      "(¬G → A10)": {
        "formal": "(¬G → A10)",
        "prover9": "(-G -> A10)",
        "prover9_expression": "(-government_agency(fda) -> identified_potential(drug_x))",
        "natural": "Provided that the FDA is not a government agency, the potential of Drug X was identified."
      },
      "(¬G → A5)": {
        "formal": "(¬G → A5)",
        "prover9": "(-G -> A5)",
        "prover9_expression": "(-government_agency(fda) -> approved_for_human_trial(drug_x))",
        "natural": "If the FDA is not a government agency, then Drug X was approved for human trial."
      },
      "A2": {
        "formal": "A2",
        "prover9": "A2",
        "prover9_expression": "published_results(study_a, journal_b)",
        "natural": "The results of Study A were published in Journal B."
      },
      "A4": {
        "formal": "A4",
        "prover9": "A4",
        "prover9_expression": "received_funding(research_team)",
        "natural": "The research team received funding."
      },
      "G": {
        "formal": "G",
        "prover9": "G",
        "prover9_expression": "government_agency(fda)",
        "natural": "The FDA is a government agency."
      },
      "¬A1": {
        "formal": "¬A1",
        "prover9": "-A1",
        "prover9_expression": "-tested_successfully(drug_x)",
        "natural": "It is not the case that Drug X was tested successfully."
      },
      "¬A10": {
        "formal": "¬A10",
        "prover9": "-A10",
        "prover9_expression": "-identified_potential(drug_x)",
        "natural": "Drug X's potential was not identified."
      },
      "¬A14": {
        "formal": "¬A14",
        "prover9": "-A14",
        "prover9_expression": "-received_regulatory_approval(drug_x)",
        "natural": "Drug X did not receive regulatory approval."
      },
      "¬A15": {
        "formal": "¬A15",
        "prover9": "-A15",
        "prover9_expression": "-launched_commercial(drug_x)",
        "natural": "Drug X was not launched commercially."
      },
      "¬A16": {
        "formal": "¬A16",
        "prover9": "-A16",
        "prover9_expression": "-partnered_pharma(drug_x)",
        "natural": "A partnership with a pharmaceutical company for Drug X does not hold."
      },
      "¬A3": {
        "formal": "¬A3",
        "prover9": "-A3",
        "prover9_expression": "-presented_findings(study_a, conference_c)",
        "natural": "The findings of Study A were not presented at Conference C."
      },
      "¬A5": {
        "formal": "¬A5",
        "prover9": "-A5",
        "prover9_expression": "-approved_for_human_trial(drug_x)",
        "natural": "Drug X was not approved for human trial."
      }
    }
  }
}